RARE
Ultragenyx Pharmaceutical Inc.When RARE passed all Ten ChecksUltragenyx Pharmaceutical Inc.
history · not a forecastOver the past 10 years, RARE has passed all Ten Checks on 10 separate days. Here is how it moved over the 20 trading sessions that followed — how far it rose, and how far it fell.
The strongest of them rose +36.2% in Dec 2019, peaked day 14.
- Dec 2025-1.1% -43.0%
- Aug 2020-1.6% -16.2%
- Jul 2020+2.9% -10.7%
Peak and dip mark the highest and lowest closing prices over those 20 sessions; the intraday swings ran wider still, and neither figure is a return you could have captured by buying and selling at the perfect moment. These are historical readings from the past 10 years, drawn only from the US-listed stocks the site covers today — a record of what happened, not a prediction of what will, and not investment advice.
6-month history — checks vs. price
Price on the left axis; checks passing (0–10) on the right.
Common questions about RARE’s checks
How many technical checks does RARE pass right now?
As of the Aug 13, 2026 close, RARE passes 8 of 10 fixed technical checks — the checks not passing: not overextended, outperforming the market.
Why does RARE fail the "outperforming the market" check?
RARE has trailed the S&P 500 by 20.4 percentage points over the last 20 sessions, so the relative-strength check fails. It passes once RARE leads the index again.
What price would change RARE's check count?
The nearest flip level is "adequate stop room" fails on a close below $26.32. Each price-anchored check has an exact next-close level, shown in the Flip levels panel above.
Factual measurements from the latest scan — not investment advice.